Substituted benzamide inhibitors of human rhinovirus 3C protease: Structure-based design, synthesis, and biological evaluation

Citation
Sh. Reich et al., Substituted benzamide inhibitors of human rhinovirus 3C protease: Structure-based design, synthesis, and biological evaluation, J MED CHEM, 43(9), 2000, pp. 1670-1683
Citations number
42
Categorie Soggetti
Chemistry & Analysis
Journal title
JOURNAL OF MEDICINAL CHEMISTRY
ISSN journal
00222623 → ACNP
Volume
43
Issue
9
Year of publication
2000
Pages
1670 - 1683
Database
ISI
SICI code
0022-2623(20000504)43:9<1670:SBIOHR>2.0.ZU;2-N
Abstract
A series of nonpeptide benzamide-containing inhibitors of human rhinovirus (HRV) 3C protease was identified using structure-based design. The design, synthesis, and biological evaluation of these inhibitors are reported. A Mi chael acceptor was combined with a benzamide core mimicking the P1 recognit ion element of the natural 3CP substrate, alpha,beta-Unsaturated cinnamate esters irreversibly inhibited the 3CP and displayed antiviral activity (EC5 0 0.60 mu M, HRV-16 infected H1-HeLa cells). On the basis of cocryrstal str ucture information, a library of substituted benzamide derivatives was prep ared using parallel synthesis on solid support. A 1.9 Angstrom cocrystal st ructure of a benzamide inhibitor in complex with the 3CP revealed a binding mode similar to that initially modeled wherein covalent attachment of the nucleophilic cysteine residue is observed. Unsaturated ketones displayed po tent reversible inhibition but were inactive in the cellular antiviral assa y and were found to react with nucleophilic thiols such as DTT.